0001562180-19-005409.txt : 20191108 0001562180-19-005409.hdr.sgml : 20191108 20191108170042 ACCESSION NUMBER: 0001562180-19-005409 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191106 FILED AS OF DATE: 20191108 DATE AS OF CHANGE: 20191108 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Raythatha Jigar CENTRAL INDEX KEY: 0001745787 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38584 FILM NUMBER: 191204801 MAIL ADDRESS: STREET 1: 215 FIRST STREET, SUITE 200 CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CONSTELLATION PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001434418 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 200 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-714-0555 MAIL ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 200 CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2019-11-06 false 0001434418 CONSTELLATION PHARMACEUTICALS INC CNST 0001745787 Raythatha Jigar C/O CONSTELLATION PHARMACEUTICALS, INC. 215 FIRST STREET, SUITE 200 CAMBRIDGE MA 02142 true true false false See Remarks Common Stock 2019-11-06 4 M false 102750.00 5.51 A 117711.00 D Common Stock 2019-11-06 4 S false 17380.00 20.1799 D 100331.00 D Common Stock 2019-11-06 4 S false 3170.00 21.1982 D 97161.00 D Common Stock 2019-11-06 4 S false 20550.00 25.0585 D 76611.00 D Common Stock 2019-11-06 4 S false 29005.00 30.1854 D 47606.00 D Common Stock 2019-11-06 4 S false 12095.00 31.3183 D 35511.00 D Common Stock 2019-11-06 4 S false 20200.00 35.2267 D 15311.00 D Common Stock 2019-11-06 4 S false 350.00 36.0071 D 14961.00 D Stock Option (Right to Buy) 5.51 2019-11-06 4 M false 102750.00 0.00 D 2027-07-10 Common Stock 102750.00 433175.00 D These trades were made pursuant to a Rule 10b5-1 trading plan. This transaction was executed in multiple trades at prices ranging from $20.00to $20.73. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $21.00 to $21.50. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $25.00 to $25.50. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $30.00 to $30.84. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $31.00 to $31.46. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $35.00 to $35.99. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $36.00 to $36.05. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This option was granted on July 11, 2017. The shares underlying the option are scheduled to vest as to 25% of the shares underlying the option on March 20, 2018, with the remainder vesting in equal quarterly installments through March 20, 2021. /s/ Emma Reeve, as Attorney-in-Fact for Jigar Raythatha 2019-11-08